Authored Content
In the final installment of our Brain Health month series, Avalere Health experts examine what it takes to close the gaps between innovation and patient access.
Emerging evidence in Alzheimer's disease highlights a gap between measured effects and lived experience, shaping how value is defined, evidenced, and assessed.
Given the uncertain challenge of future international price referencing by the US, Avalere Health considers implications for global market access.
Uncovering beliefs underpinning payer decision making can help global access teams achieve optimal and equitable patient access, faster.
With global market access teams navigating a rapidly changing environment, there are several key concepts reshaping how access teams think, plan, and operate to deliver real-word patient access.